Purchase Order 36C24420P0912
- Not listed
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, a $126,652.50 firm-fixed-price purchase order for BioFire RP2.1 panel reagents. The contract has a completion date of February 15, 2022 and was awarded on December 3, 2020. Biofire Diagnostics is a leader in syndromic infectious disease testing and has received numerous federal contracts from agencies such as the VA, Defense Health Agency,...
- The Department of Veterans Affairs Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Biofire Diagnostics LLC, a foreign-owned for-profit organization, to provide COVID-19 testing kits. The $230,850 contract has a period of performance from July 2020 to July 2021 and is not associated with a set-aside program. Biofire Diagnostics is a leader in syndromic infectious disease testing and has received numerous federal contracts to provide diagnostic testing services,...
- This is a firm-fixed price task order awarded to Biofire Diagnostics LLC under a blanket purchase agreement (BPA) with the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) for COVID-19 laboratory testing and support services. The task order has a ceiling value of $56,712 and a period of performance through July 18, 2024. Biofire Diagnostics LLC is a for-profit, foreign-owned company that specializes in syndromic infectious disease testing. The company has a General...
- This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network (VISN) 10 to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide 60 COVID-19 testing panels and reagents. The purchase order, valued at $230,850.00, was awarded on October 1, 2020 with a completion date of September 30, 2021. No set-aside designation was used. The VA awarded this sole-source contract under...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in infectious disease testing. The $110,160.00 firm-fixed-price purchase order was issued under the VA VISN 9 network for COVID-19 panel testing using Biofire's 423738 COVID emergency testing products. No set-aside was used. Biofire Diagnostics has held numerous federal contracts with the VA,...
- This $172,948.90 firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, for the delivery of BIOFIRE REAGENT. The contract has a completion date of May 15, 2021 and was awarded on July 14, 2020 with no set-aside designation used. Biofire Diagnostics is the leader in syndromic infectious disease testing and has received numerous federal contracts to provide...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit organization that specializes in syndromic infectious disease testing. The $125,500.00 firm-fixed-price purchase order does not have a set-aside designation. Biofire Diagnostics LLC has received numerous federal contracts as a prime contractor to provide a variety of goods and services related to infectious disease...
- This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company, to provide COVID-19 testing reagents. The $223,560 firm fixed-price purchase order has a completion date of September 30, 2021. Biofire Diagnostics LLC has received numerous federal contracts to supply infectious disease testing products and services, including molecular diagnostic testing, reagents, and maintenance...
- This is a delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company that specializes in syndromic infectious disease testing. The $121,440.00 firm fixed-price contract is for the provision of BIOFIRE diagnostic products and services, issued under Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents,...
- This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit biotech company. The contract is for $265,350.00 and was awarded on May 15, 2018 with a completion date of July 9, 2018. The work is not set-aside and is being performed under Biofire's General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests. Biofire...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Biofire Diagnostics LLC, a foreign-owned for-profit organization, for the provision of BIOFIRE RP2.1 RESPIRATORY PANEL COVID-19 TESTING. The contract, which does not have a set-aside designation, has a potential value of $115,425.00 and a completion date of November 30, 2021. Biofire Diagnostics LLC is a leader in syndromic infectious disease testing and has received numerous federal contract awards from agencies such as the VA, Defense Health Agency, and Indian Health Service to provide a variety of diagnostic testing products and services. This award is likely part of Biofire's existing General Services Administration (GSA) Federal Supply Schedule contract for in-vitro diagnostics, reagents, and tests, or another agency-specific contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $115.4k | 9/25/20 |